Abstract
Abstract
Background
Access to safe, effective, quality and affordable essential medicines for all is a central component of Universal Health Coverage (UHC). However, the availability of quality medicines in peripheral healthcare facilities is often limited. Several countries have developed integrated complementary pharmaceutical supply systems to address the shortage of medicines. Nevertheless, there is little evidence on how accountability contributes to the performance of such complementary pharmaceutical supply systems in low-income settings. The current study analyses how accountability mechanisms contributed to the performance of Jazia Prime Vendor System (Jazia PVS) in Tanzania.
Methods
The study analysed financial, performance and procedure accountability as defined in Boven’s accountability framework. We conducted 30 in-depth interviews (IDIs), seven group discussions (GD) and 14 focus group discussions (FGDs) in 2018 in four districts that implemented Jazia PVS. We used a deductive and inductive approach to develop the themes and framework analysis to summarize the data.
Results
The study findings revealed that a number of accountability mechanisms implemented in conjunction with Jazia PVS contributed to the performance of Jazia PVS. These include inventory and financial auditing conducted by district pharmacists and the internal auditors, close monitoring of standard operating procedures by the prime vendor regional coordinating office and peer cascade coaching. Furthermore, the auditing activities allowed identifying challenges of delayed payment to the vendor and possible approaches for mitigation while peer cascade coaching played a crucial role in enabling staff at the primary facilities to improve skills to oversee and manage the medicines supply chain.
Conclusion
Financial, performance and procedure accountability measures played an important role for the successful performance of Jazia PVS in Tanzania. The study highlights the need for capacity building linked to financial and supply management at lower level health facilities, including health facility governing committees, which are responsible for priority-setting and decision-making at facility level.
Funder
Swiss Programme for Research on Global Issues for Development (r4d), Swiss Agency for Development and Cooperation (SDC), Swiss National Science Foundation
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Wirtz V, Hogerzeil H, Gray A, Bigdeli M, Joncheere C, Ewen M, et al. Essential medicines for universal health coverage. Lancet. 2017;389(10067):403–76.
2. Paschke A, Dimancesco D, Vian T, Kohlerd J, Forteb G. Increasing transparency and accountability in national pharmaceutical systems. Bull World Health Organ. 2018;96(11):782–91.
3. Stevens H, Huys I. Innovative approaches to increase access to medicines in developing countries. Front Med. 2017;4:218.
4. Karwa R, Tran D, Maina M, Njuguna B, Manji I, Wasike P, et al. Addressing the 3A’s (Availability, Accountability, Adherence) of supply chain systems in Western Kenya; 2017. p. 129–57.
5. Ahmadiani S, Nikfar S. Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective. Daru. 2016;24(1):13.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献